Submit Manuscript    >>    Login | Register

Management of Atrial Fibrillation in Patients with Kidney Disease

The increasing burden of Chronic Kidney Disease (CKD) is highly relevant to cardiologists, as cardiovascular mortality is 10-30 times higher amongst people with ESRD, comparing with general population. One of the commonest associations is the increased frequency of atrial fibrillation (AF) amongst those experiencing CKD.


Overall, we know that AF is the most common cardiac arrhythmia. AF leads to a substantial risk of mortality and morbidity, from stroke and thromboembolism, heart failure, reduced cognitive function and impaired quality of life.  However, most clinical trials in AF (for example, for stroke prevention in AF with anticoagulation therapy) have largely excluded patients with significant renal impairment. 


In this review article, we will focus on stroke prevention in AF, and the clinical impact of CKD and its implications for management.

Credits: Yee C Lau; Gregory Y H Lip

Biosense Webster
event date
Introduction to AFib
Ablation Specialist

View Ablation Specialists